Changing the course of cancer treatment - We harness the power of the body's immune system to keep tumor cells in check.
Investors 1
| Date | Name | Website |
| - | BioVenture... | azbioventu... |
Mentions in press and media 2
| Date | Title | Description |
| 01.12.2025 | NorthX Biologics achieves milestone GMP certification to manufacture vididencel – Mendus’ lead cell therapy product for acute and chronic myeloid leukemias | NorthX Biologics achieves milestone GMP certification to manufacture vididencel – Mendus’ lead cell therapy product for acute and chronic myeloid leukemias Mon, Dec 01, 2025 08:30 CET Report this content Off-the-shelf cellular immunotherapy... |
| 12.03.2024 | Mendus provides business update and outlook for vididencel program | - |